Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1978 1
1980 2
1981 2
1982 2
1983 5
1984 5
1985 4
1986 12
1987 9
1988 9
1989 7
1990 5
1991 4
1992 4
1993 2
1994 6
1995 1
1996 1
1997 3
1998 4
1999 1
2000 2
2004 1
2005 1
2006 1
2007 1
2008 2
2010 2
2011 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacovigilance in perspective.
Meyboom RH, Egberts AC, Gribnau FW, Hekster YA. Meyboom RH, et al. Among authors: gribnau fw. Drug Saf. 1999 Dec;21(6):429-47. doi: 10.2165/00002018-199921060-00001. Drug Saf. 1999. PMID: 10612268 Review.
Second-line treatment in seronegative spondylarthropathies.
Creemers MC, van Riel PL, Franssen MJ, van de Putte LB, Gribnau FW. Creemers MC, et al. Among authors: gribnau fw. Semin Arthritis Rheum. 1994 Oct;24(2):71-81. doi: 10.1016/s0049-0172(05)80001-0. Semin Arthritis Rheum. 1994. PMID: 7839156 Review.
Principles of signal detection in pharmacovigilance.
Meyboom RH, Egberts AC, Edwards IR, Hekster YA, de Koning FH, Gribnau FW. Meyboom RH, et al. Among authors: gribnau fw. Drug Saf. 1997 Jun;16(6):355-65. doi: 10.2165/00002018-199716060-00002. Drug Saf. 1997. PMID: 9241490 Review.
Mechanisms of drug transfer across the human placenta.
van der Aa EM, Peereboom-Stegeman JH, Noordhoek J, Gribnau FW, Russel FG. van der Aa EM, et al. Among authors: gribnau fw. Pharm World Sci. 1998 Aug;20(4):139-48. doi: 10.1023/a:1008656928861. Pharm World Sci. 1998. PMID: 9762726 Review.
Gap in publication of comparative information on new medicines.
van Luijn JC, Stolk P, Gribnau FW, Leufkens HG. van Luijn JC, et al. Among authors: gribnau fw. Br J Clin Pharmacol. 2008 May;65(5):716-22. doi: 10.1111/j.1365-2125.2007.03092.x. Epub 2008 Feb 21. Br J Clin Pharmacol. 2008. PMID: 18294324 Free PMC article. Review.
Risk factors of second-line antirheumatic drugs in rheumatoid arthritis.
Wijnands MJ, van Riel PL, Gribnau FW, van de Putte LB. Wijnands MJ, et al. Among authors: gribnau fw. Semin Arthritis Rheum. 1990 Jun;19(6):337-52. doi: 10.1016/0049-0172(90)90071-m. Semin Arthritis Rheum. 1990. PMID: 2196675 Review. No abstract available.
Transcutaneous absorption of naproxen gel.
van den Ouweland FA, Eenhoorn PC, Tan Y, Gribnau FW. van den Ouweland FA, et al. Among authors: gribnau fw. Eur J Clin Pharmacol. 1989;36(2):209-11. doi: 10.1007/BF00609198. Eur J Clin Pharmacol. 1989. PMID: 2721545
Hypersensitivity to ethambutol.
Kerremans A, Majoor CL, Gribnau FW. Kerremans A, et al. Among authors: gribnau fw. Tubercle. 1981 Sep;62(3):215-7. doi: 10.1016/0041-3879(81)90010-6. Tubercle. 1981. PMID: 7314255 No abstract available.
Superior efficacy of new medicines?
van Luijn JC, Gribnau FW, Leufkens HG. van Luijn JC, et al. Among authors: gribnau fw. Eur J Clin Pharmacol. 2010 May;66(5):445-8. doi: 10.1007/s00228-010-0808-3. Epub 2010 Mar 12. Eur J Clin Pharmacol. 2010. PMID: 20224944 Free PMC article.
99 results